Psoriasis

Articles 545-560 of 650

News
Samsung Biologics to Manufacture Sun Pharma's Tildrakizumab for Psoriasis
 
Sun Pharmaceutical Industries just inked a long-term agreement with South Korea’s Samsung BioLogics to manufacture Tildrakizumab for psoriasis.
The investigational IL-23p19 inhibitor drug is currentl...
07/04/2017



News

PsA Patients Failing Anti-TNF Drugs May Do Well on Taltz

06/14/2017



News

Tildrakizumab Performs Well in Two Phase 3 Psoriasis Studies

06/06/2017



News

FDA Clears Clarify Medical Core Technology for At-home UVB Phototherapy

06/05/2017



News

Game Change: New Handheld Tissue Scanner Can See Below Surface of Skin in Psoriasis

06/05/2017



News

Sun Pharma Announces US FDA Filing Acceptance of Biologics License Application For Tildrakizumab

05/23/2017
News
Largest Psoriasis Meta-Analysis to Date Yields New Genetic Clues
 
A new meta -analysis identifies 16 additional genetic markers that may help researchers get closer to understanding how — and why — psoriasis develops.
University of Michigan researchers, working wit...
05/23/2017



News

Tweaking TWEAK May Cool Inflammation in Pso and AD

05/22/2017
News
Valeant Dermatology Announces New Senior Leadership Team in Advance of SILIQ Launch
 
Valeant Dermatology announced a new senior leadership team, led by Bill Humphries, executive vice president and group chairman. 
The team includes Michael McMyne, vice president of sales; Stacey Will...
05/16/2017



News

LEO Pharma U.S. Welcomes Judit H. Nyirady as Vice President of Medical Strategy & Scientific Affairs

05/03/2017
News
Pfizer Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for XELJANZ® (tofacitinib citrate) for the Treatment of Adult Patients with Active Psoriatic Arthritis
 
(via BusinessWire) Pfizer Inc. announced today that the United States Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for XELJANZ® (tofacitinib ...
05/03/2017
News
ASA Honors Researchers At Annual Meeting of the Society for Investigative Dermatology
 
Richard Edelson, MD Chair and Professor, Department of Dermatology, Yale School of Medicine, took home the David Martin Carter Mentor Award from the American Skin Association at the Annual Meeting of ...
04/26/2017
News
Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ as Lowest Priced Injectable Biologic For Psoriasis
 
Following the evaluation and approval of its Patient Access and Pricing Committee (PAPC), Valeant Pharmaceuticals International, Inc. has decided to list SILIQ (brodalumab) injection at $3,500 per mon...
04/20/2017
News
Topical Cannabinoids May Soothe Itchy Skin
 
Cannabinoids contain anti-inflammatory properties that may make them useful in the treatment of a wide-range of skin diseases including  eczema, psoriasis, atopic and contact dermatitis, according to ...
04/18/2017



News

FDA Approves Addition of Moderate to Severe Fingernail Psoriasis Data to Humira Prescribing Information

03/29/2017
News
Study: Severe Psoriasis More Common in Men
 
Severe psoriasis predominantly affects men, according to a new study in the American Journal of Clinical Dermatology.
In the study of 5,438 Swedish psoriasis patients, women had significantly (p<0.00...
03/23/2017